Updated Aug. 13, 2015 at 12:16 p.m.

Premium Lock RTP's G1 Therapeutics begins clinical trials of chemoprotectant in lung cancer patients

Published: 2015-08-13 12:14:00
Updated: 2015-08-13 12:16:03

G1 G1 Image 1 of 2 · Next Image…

G1 Therapeutics, a Research Triangle Park clinical-stage oncology company backed by Fred Eshelman, has begun two clinical trials of a new therapy aimed at protecting the bone marrow and immune systems of patients undergoing chemotherapy for small-cell lung cancer....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders